Recombinant IL13 (Lebrikizumab Biosimilar) 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant IL13 (Lebrikizumab Biosimilar) 抗体 (ABIN7829211)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
原理
- Anti-IL13(lebrikizumab biosimilar) mAb
-
亚型
- IgG4
-
-
-
-
说明
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
缓冲液
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
有效期
- 12 months
-
-
- IL13 (Lebrikizumab Biosimilar)
-
别名
- Lebrikizumab Biosimilar
-
物质类
- Biosimilar
-
背景
-
Synonyms Target:P600,IL-13,NC30
Synonyms Antibody:DRM 06,DRM-06,DRM06,DRM 6,DRM-6,DRM6,LY 3650150,LY-3650150,LY3650150,MILR1444A,MILR-1444A,MILR 1444,ARG 3637,ARG-3637,ARG3637,RO 5490255,RO-5490255,RO5490255,TNX 650,TNX-650,TXN650 -
UniProt
- P35225
抗原
-